학술논문
Induction Therapy with Everolimus in Combination with DHAP (Dexamethasone, High-Dose AraC, Cisplatinum) in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma: A Randomized, Placebo-Controlled Phase I/II Trial (HD-R3i)
Document Type
Abstract
Author
Source
In Blood 29 November 2018 132 Supplement 1:2912-2912
Subject
Language
ISSN
0006-4971